Maltose binding protein facilitates high-level expression and functional purification of the chemokines RANTES and SDF-1α from Escherichia coli

Protein Expression and Purification

Volumn 60, Issue 1, 2008, Pages 37-45

  Cho, Hee Jeong ^a   Lee, Young ^a   Chang, Rae Sung ^a   Hahm, Moon Sun ^b   Kim, Myung Kuk ^b   Kim, Young Bong ^c   Oh, Yu Kyoung ^a  

^a Korea University   (South Korea)

^b Bioprogen   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

Chemokine; Escherichia coli; Fusion protein; RANTES; SDF 1

Indexed keywords

CARRIER PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; MALTOSE-BINDING PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1;

ANIMAL; ARTICLE; ESCHERICHIA COLI; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CHEMOKINE CCL5; CHEMOKINE CXCL12; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS;

ANIMALIA; ESCHERICHIA COLI;

EID: 43649096700     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.03.018     Document Type: Article

References (29)

1. Moser B., and Willimann K. Chemokines: role in inflammation and immune surveillance. Ann. Rheum. Dis. 63 Suppl. 2 (2004) ii84-ii89
2. Rodríguez-Frade J.M., Martínez-A C., and Mellado M. Chemokine signaling defines novel targets for therapeutic intervention. Mini Rev. Med. Chem. 5 (2005) 781-789
3. Palmqvist C., Wardlaw A.J., and Bradding P. Chemokines and their receptors as potential targets for the treatment of asthma. Br. J. Pharmacol. 151 (2007) 725-736
4. Rostène W., Kitabgi P., and Parsadaniantz S.M. Chemokines: a new class of neuromodulator. Nat. Rev. Neurosci. 8 (2007) 895-903
5. Krensky A.M., and Ahn Y.T. Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat. Clin. Pract. Nephrol. 3 (2007) 164-170
6. Llano A., Barretina J., Gutiérrez A., Clotet B., and Esté J.A. Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression. J. Virol. 77 (2003) 4389-4395
7. Miranda L.P., Shao H., Williams J., Chen S.Y., Kong T., Garcia R., Chinn Y., Fraud N., O'Dwyer B., Ye J., Wilken J., Low D.E., Cagle E.N., Carnevali M., Lee A., Song D., Kung A., Bradburne J.A., Paliard X., and Kochendoerfer G.G. A chemical approach to the pharmaceutical optimization of an anti-HIV protein. J. Am. Chem. Soc. 129 (2007) 13153-13159
8. Kim S.J., Lee C., Lee S.Y., Kim I., Park J.S., Sasagawa T., Ko J.J., Park S.E., and Oh Y.K. Enhanced immunogenicity of human papillomavirus 16 L1 genetic vaccines fused to an ER-targeting secretory signal peptide and RANTES. Gene Ther. 10 (2003) 1268-1273
9. Kim S.J., Suh D., Park S.E., Park J.S., Byun H.M., Lee C., Lee S.Y., Kim I., and Oh Y.K. Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES. Virology 314 (2003) 84-91
10. Tan Y., Du J., Cai S., Li X., Ma W., Guo Z., Chen H., Huang Z., Xiao J., Cai L., and Cai S. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal α-helix of SDF-1α plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity. Exp. Hematol. 34 (2006) 1553-1562
11. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., Ratajczak J., and Ratajczak M.Z. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
12. Lima e Silva R., Shen J., Hackett S.F., Kachi S., Akiyama H., Kiuchi K., Yokoi K., Hatara M.C., Lauer T., Aslam S., Gong Y.Y., Xiao W.H., Khu N.H., Thut C., and Campochiaro P.A. The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J. 21 (2007) 3219-3230
13. Bajetto A., Barbieri F., Pattarozzi A., Dorcaratto A., Porcile C., Ravetti J.L., Zona G., Spaziante R., Schettini G., and Florio T. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro Oncol. 9 (2007) 3-11
14. Proudfoot A.E., and Borlat F. Chemokine Protocols (2002), Humana Press, New York pp. 75-87
15. Veldkamp C.T., Peterson F.C., Pelzek A.J., and Volkman B.F. The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci. 14 (2005) 1071-1081
16. Scheich C., Sievert V., and Bussow K. An automated method for high-throughput protein purification applied to a comparison of His-tag and GST-tag affinity chromatography. BMC Biotechnol. 3 (2003) 12-19
17. Zhang Y.D., Zhou J., Zhao J.F., Peng J., Liu X.D., Liu X.S., and Jia Z.M. Expression, purification and bioactivity of human augmenter of liver regeneration. World J. Gastroenterol. 12 (2006) 4401-4405
18. Rabhi-Essafi I., Sadok A., Khalaf N., and Fathallah D.M. A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli. Protein Eng. Des. Sel. 20 (2007) 201-209
19. Tolia N.H., and Joshua-Tor L. Strategies for protein coexpression in Escherichia coli. Nat. Methods 3 (2006) 55-64
20. Smyth D.R., Mrozkiewicz M.K., McGrath W.J., Listwan P., Kobe B., Smyth D.R., and Mrozkiewicz M.K. Crystal structures of fusion proteins with large-affinity tags. Protein Sci. 12 (2003) 1313-1322
21. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. second ed. (1989), Cold Spring Harbor Laboratory Press, New York
22. Huang H., Liu J., and de Marco A. Induced fit of passenger proteins fused to Archaea maltose binding proteins. Biochem. Biophys. Res. Commun. 344 (2006) 25-29
23. Cho H.J., Hahm M.S., Kim M.K., Han I.K., Jung W.W., Choi H.G., Kim J.A., and Oh Y.K. Expression, purification, and antibody binding activity of human papillomavirus 16 L1 protein fused to maltose binding protein. Protein Pept. Lett. 14 (2007) 417-424
24. Bhattacharya P., Pandey G., Srivastava P., and Mukherjee K.J. Combined effect of protein fusion and signal sequence greatly enhances the production of recombinant human GM-CSF in Escherichia coli. Mol. Biotechnol. 30 (2005) 103-116
25. Fox J.D., Kapust R.B., and Waugh D.S. Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins. Protein Sci. 10 (2001) 622-630
26. McNulty D.E., Claffee B.A., Huddleston M.J., Porter M.L., Cavnar K.M., and Kane J.F. Mistranslational errors associated with the rare arginine codon CGG in Escherichia coli. Protein Expr. Purif. 27 (2003) 365-374
27. Sørensen H.P., and Mortensen K.K. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol. 115 (2005) 113-128
28. Magistrelli G., Gueneau F., Muslmani M., Ravn U., Kosco-Vilbois M., and Fischer N. Chemokines derived from soluble fusion proteins expressed in Escherichia coli are biologically active. Biochem. Biophys. Res. Commun. 334 (2005) 370-375
29. Veldkamp C.T., Peterson F.C., Hayes P.L., Mattmiller J.E., Haugner J.C., delaCruz N., and Volkman B.F. On-column refolding of recombinant chemokines for NMR studies and biological assays. Protein Expr. Purif. 52 (2007) 202-209